Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 43.31B | 44.55B | 40.98B | 41.95B | 41.68B | 41.17B |
Gross Profit | 33.96B | 34.77B | 32.43B | 33.17B | 31.88B | 29.91B |
EBITDA | 19.15B | 20.62B | 19.27B | 21.09B | 19.04B | 16.87B |
Net Income | 12.08B | 12.33B | 11.64B | 13.40B | 12.16B | 10.96B |
Balance Sheet | ||||||
Total Assets | 117.38B | 121.04B | 109.10B | 99.46B | 86.22B | 75.40B |
Cash, Cash Equivalents and Short-Term Investments | 97.41B | 100.57B | 89.85B | 80.14B | 67.15B | 56.01B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 14.84B | 16.01B | 15.10B | 15.78B | 14.92B | 14.33B |
Stockholders Equity | 102.53B | 105.03B | 94.00B | 83.68B | 71.30B | 61.07B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 14.98B | 10.53B | 14.31B | 12.12B | 11.16B |
Operating Cash Flow | 0.00 | 15.02B | 13.05B | 16.80B | 14.08B | 12.99B |
Investing Cash Flow | 0.00 | -27.13B | -8.56B | -3.85B | -2.02B | -3.82B |
Financing Cash Flow | 0.00 | -1.28B | -1.28B | -1.03B | -1.03B | -641.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥3.82T | 26.72 | 1.25% | 5.67% | 38.70% | ||
74 Outperform | ¥1.49T | 30.15 | 1.50% | 33.00% | 21.00% | ||
73 Outperform | ¥248.23B | 20.14 | 0.52% | 4.47% | -1.74% | ||
72 Outperform | $637.47B | 33.20 | 13.64% | 0.43% | 6.92% | 25.38% | |
70 Outperform | $6.28T | 16.29 | 11.82% | 0.82% | -8.36% | 45.42% | |
69 Neutral | $2.67T | 35.81 | 16.06% | 0.69% | 8.65% | 12.22% | |
69 Neutral | ¥234.01B | 14.95 | 7.54% | 2.58% | 9.26% | 5.89% |